Detalles de la búsqueda
1.
Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study §.
Sensors (Basel);
21(18)2021 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34577338
2.
Real-time continuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta-analysis.
Clin Endocrinol (Oxf);
86(3): 354-360, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27978595
3.
Differential effects of glucagon-like peptide-1 receptor agonists on heart rate.
Cardiovasc Diabetol;
16(1): 6, 2017 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28086882
4.
A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin.
Diabetes Metab Res Rev;
33(3)2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27606888
5.
Efficacy and safety of lixisenatide in elderly (≥65 years old) and very elderly (≥75 years old) patients with type 2 diabetes: an analysis from the GetGoal phase III programme.
Diabetes Metab Res Rev;
31(2): 204-11, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25115916
6.
Lixisenatide as add-on to oral anti-diabetic therapy: an effective treatment for glycaemic control with body weight benefits in type 2 diabetes.
Diabetes Metab Res Rev;
30(8): 742-8, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24687427
7.
Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring Systems in a Type 1 Diabetes Patient French Cohort: An Observational Study of Clinical Practices.
Diabetes Technol Ther;
23(4): 259-267, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33136439
8.
Fixed-Ratio Combination of Insulin and GLP-1 RA in Patients with Longstanding Type 2 Diabetes: A Subanalysis of LixiLan-L.
Diabetes Ther;
11(4): 1007-1015, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32166620
9.
Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: An electronic medical record database analysis.
Endocrinol Diabetes Metab;
2(3): e00061, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31294079
10.
Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial.
Lancet Digit Health;
1(1): e17-e25, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33323237
11.
Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin.
Diabetes Ther;
9(3): 1169-1184, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29675797
12.
Safety and tolerability of glucagon-like peptide-1 receptor agonists: unresolved and emerging issues.
Expert Opin Drug Saf;
16(2): 227-236, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27924636
13.
Individualized, patient-centered use of lixisenatide for the treatment of type 2 diabetes mellitus.
Expert Opin Drug Metab Toxicol;
13(3): 311-321, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27776453
14.
[Diabetes mellitus and renal tubule functions]. / Tubule et diabête. Fonction tubulaire et rein diabétique.
Nephrol Ther;
2 Suppl 1: S28-31, 2006 Jan.
Artículo
en Francés
| MEDLINE | ID: mdl-17378137
15.
Reply to Letter by Alexander Seibold on "Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring Systems in a Type 1 Diabetes Patient French Cohort: An Observational Study of Clinical Practices" by Yannis Préau, et al. (doi: 10.1089/dia.2020.0674).
Diabetes Technol Ther;
23(8): 598-600, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33635737
16.
Health and Pleasure in Consumers' Dietary Food Choices: Individual Differences in the Brain's Value System.
PLoS One;
11(7): e0156333, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27428267
17.
Neuroprotective effect of docosahexaenoic acid-enriched phospholipids in experimental diabetic neuropathy.
Diabetes;
52(10): 2578-85, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-14514643
18.
A randomized trial of low-protein diet in type 1 and in type 2 diabetes mellitus patients with incipient and overt nephropathy.
J Ren Nutr;
15(4): 398-406, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16198932
19.
Glycemic and insulinemic meal responses modulate postprandial hepatic and intestinal lipoprotein accumulation in obese, insulin-resistant subjects.
Am J Clin Nutr;
80(4): 896-902, 2004 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15447896
20.
Once-daily prandial lixisenatide versus once-daily rapid-acting insulin in patients with type 2 diabetes mellitus insufficiently controlled with basal insulin: analysis of data from five randomized, controlled trials.
J Diabetes Complications;
28(1): 40-4, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24246441